9036 J . Org. Chem., Vol. 66, No. 26, 2001
Notes
(3), 4-bromomethyl-2,5-diphenyloxazole (1) (314 mg, 1.00 mmol)
and tributyl(vinyl)tin (351 µL; 381 mg, 1.20 mmol) were coupled
together to form 4-allyl-2,5-diphenyloxazole (4), after flash
column chromatography (10% diethyl ether in hexanes), as a
white solid (257 mg, 98%), mp 60-62 °C. IR (KBr) νmax/cm-1
organic extracts were washed with a saturated aqueous solution
of ammonium chloride (4 × 25 mL), dried over magnesium
sulfate, and concentrated under reduced pressure to give a
yellow solid. Flash chromatography (10% diethyl ether in
hexanes) gave 2,5-diphenyl-4-(4′-vinylbenzyl)oxazole (6) as a
white solid (321 mg, 95%), mp 106-108 °C. IR (KBr) νmax/cm-1
1
3058, 2956, 2922, 2853, and 1638; H NMR (300 MHz, CDCl3)
1
δH 3.64 (2H, dt, J ) 6, 2 Hz), 5.29-5.21 (2H, m), 6.10-6.23 (1H,
m), 7.32-7.51 (6H, m), 7.68-7.72 (2H, m), and 8.12-8.17 (2H,
m); 13C NMR (75 MHz, PENDANT, CDCl3) δC 31.5, 116.3, 125.4,
126.2, 127.3, 127.7, 128.5, 128.6, 130.0, 134.4, 135.0, 144.9, 145.9,
and 159.6; LRMS (APCI) m/z 262 (M + H+).
3057, 2925, and 1654; H NMR (300 MHz, CDCl3) δH 4.28 (2H,
s), 5.27 (1H, d, J ) 10.9 Hz), 5.78 (1H, d, J ) 17.6 Hz), 6.77
(1H, dd, J ) 17.6, 10.9 Hz), 7.35-7.54 (10H, m), 7.74-7.77 (2H,
m), and 8.21 (2H, dd, J ) 7.9, 1.8 Hz); 13C NMR (75 MHz,
PENDANT, CDCl3) δC 32.8, 113.1, 125.4, 125.8, 126.2, 126.3,
127.3, 127.8, 128.4, 128.5, 128.7, 130.0, 135.5, 135.7, 136.4, 138.1,
146.3, and 159.7; LRMS (APCI) m/z 338 (M + H+). Found C,
85.2; H, 5.6; N, 4.1; C24H19NO requires C, 85.4; H, 5.6; N, 4.1.
2,5-Dip h en yl-4-(4′-vin ylp h en yl)oxa zole (Ta ble 2, En tr y
2). Using the same procedure as described for the preparation
of 2,5-diphenyl-4-(4′-vinylbenzyl)oxazole (6), 2,5-diphenyl-4-
tributylstannanyloxazole (5b) (612 mg, 1.20 mmol) was coupled
to 4-bromostyrene (131 µL, 183 mg, 1.0 mmol). Tri-2-furylphos-
phine (46 mg, 200 µmol) was used as the ligand, and a reaction
time of 16 h at 65 °C and purification by flash column chroma-
tography (4% diethyl ether in hexanes) gave 2,5-diphenyl-4-(4′-
vinylphenyl)oxazole as a white solid (187 mg, 58%), mp 76-78
°C. IR (KBr) νmax/cm-1 3054, 2925, and 1654; 1H NMR (300 MHz,
CDCl3) δH 5.33 (1H, d, J ) 10.9 Hz), 5.84 (1H, d, J ) 17.6 Hz),
6.78 (1H, dd, J ) 17.6, 10.9 Hz), 7.38-7.53 (8H, m), 7.71-7.78
(4H, m), and 8.18-8.22 (2H, m); 13C NMR (75 MHz, PENDANT,
CDCl3) δC 114.1, 126.4, 126.5, 126.6, 127.3, 128.1, 128.5, 128.6,
128.64, 128.9, 129.1, 130.2, 131.9, 136.4, 137.3, 145.5, and 160.1;
LRMS (APCI) m/z 324 (M + H+).
4-Ben zyl-2,5-d ip h en yloxa zole (Ta ble 1, En tr y 5). Using
the same procedure as described for the preparation of 2,5-
diphenyl-4-vinyloxazole (3), 4-bromomethyl-2,5-diphenyloxazole
(1) (314 mg, 1.00 mmol) and tributylphenyltin (392 µL; 441 mg,
1.20 mmol) were coupled together at 100 °C for 3 h to form
4-benzyl-2,5-diphenyloxazole, after flash column chromatogra-
phy (7.5% diethyl ether in hexanes), as a white solid (262 mg,
84%), mp 90-92 °C. IR (KBr) νmax/cm-1 3059, 3023, and 2921;
1H NMR (300 MHz, CDCl3) δH 4.32 (2H, s), 7.31-7.56 (11H, m),
7.75-7.78 (2H, m), and 8.20-8.24 (2H, m); 13C NMR (75 MHz,
PENDANT, CDCl3) δC 33.2, 125.6, 126.4, 127.5, 128.0, 128.5,
128.6, 128.7, 128.9, 130.2, 135.8, 138.6, 146.5, and 159.9; LRMS
(APCI) m/z 312 (M + H+).
2,5-Dip h en yl-4-tr im eth ylsta n n a n yloxa zole (5a ). To a so-
lution of 2,5-diphenyloxazole (8.21 g, 37.1 mmol) and 2,2,6,6-
tetramethylpiperidine (0.63 mL; 0.53 g, 3.73 mmol) in tetrahy-
drofuran (150 mL) cooled to -78 °C was added sec-butyllithium
(1.3 M solution in cyclohexane, 31.5 mL, 40.1 mmol) over 30 min.
The mixture was allowed to warm to 0 °C over 30 min, and the
resultant solution, containing 2,5-diphenyl-4-lithio-oxazole, was
added via cannula to a solution, cooled to -78 °C, of trimethyltin
chloride (7.40 g, 37.1 mmol) in tetrahydrofuran (50 mL). After
the mixture was warmed to room temperature, the reaction was
quenched cautiously by the addition of a saturated aqueous
solution of ammonium chloride (100 mL). The organic layer was
separated, dried over magnesium sulfate, and concentrated
under reduced pressure to give a dark red solid. Recrystallization
from methanol gave 2,5-diphenyl-4-trimethylstannanyloxazole
4-Bip h en yl-4-yl-2,5-d ip h en yloxa zole (Ta ble 2, En tr y 3).
Using the same procedure as described for the preparation of
2,5-diphenyl-4-(4′-vinylbenzyl)oxazole (6), 2,5-diphenyl-4-tribu-
tylstannanyloxazole (5b) (612 mg, 1.20 mmol) was coupled to
4-bromobiphenyl (233 mg, 1.0 mmol). Tri-2-furylphosphine (46
mg, 200 µmol) was used as the ligand, and a reaction time of 24
h at 65 °C and purification by flash column chromatography (5%
diethyl ether in hexanes) gave 4-biphenyl-4-yl-2,5-diphenylox-
azole as a white solid (190 mg, 51%), mp 79-81 °C. IR (KBr)
(5a ) (9.50 g, 67%) as a white solid; mp 80-82 °C. IR (KBr) νmax
/
ν
max/cm-1 3056 and 1697; 1H NMR (300 MHz, CDCl3) δH 7.37-
cm-1 3057, 2981, and 2906; 1H NMR (300 MHz, CDCl3) δH 0.50
(9H, s), 7.37-7.54 (6H, m), 7.71-7.75 (2H, m), and 8.18-8.22
(2H, m); 13C NMR (75 MHz, PENDANT, CDCl3) δC -8.7, 125.7,
126.3, 127.8, 128.1, 128.5, 128.6, 129.7, 129.8, 136.0, 157.5, and
161.7; LRMS (APCI) m/z 386 (M + H+).
7.56 (9H, m), 7.67-7.71 (4H, m), 7.76-7.79 (2H, m), 7.85-7.89
(2H, m), and 8.19-8.22 (2H, m); 13C NMR (75 MHz, PENDANT,
CDCl3) δC 126.4, 126.6, 127.0, 127.2, 127.4, 128.4, 128.6, 128.65,
128.7, 128.75, 129.0, 130.3, 131.5, 136.4, 140.6, 140.8, 145.6, and
160.1; LRMS (APCI) m/z 374 (M + H+).
2,5-Dip h en yl-4-tr ibu tylsta n n a n yloxa zole (5b). Using the
same procedure as described for the preparation of 2,5-diphenyl-
4-trimethylstannanyloxazole (5a ), the lithiated anion of 2,5-
diphenyloxazole (8.84 g, 40.0 mmol) and tributyltin chloride (10.9
mL, 13.1 g, 40.2 mmol) were reacted together to give 2,5-
diphenyl-4-tributylstannanyloxazole (5b), after flash column
chromatography (gradient elution with 0-3% diethyl ether in
hexanes), as a colorless oil (15.4 g, 75%). IR (film) νmax/cm-1 3032,
2955, 2924, and 2851; 1H NMR (300 MHz, CDCl3) δH 0.85-1.60
(27H, m), 7.34-7.48 (6H, m), 7.66-7.69 (2H, m), and 8.14 (2H,
dd, J ) 8.3, 1.8 Hz); 13C NMR (75 MHz, PENDANT, CDCl3) δC
10.4, 13.7, 27.2, 29.0, 125.8, 126.4, 128.1, 128.6, 128.65, 129.7,
130.2, 132.0, 136.4, 157.8, 161.7; LRMS (APCI) m/z 512 (M +
2,5-Dip h en yl-4-th iop h en -2-yloxa zole (Ta ble 2, En tr y 4).
Using the same procedure as described for the preparation of
2,5-diphenyl-4-(4′-vinylbenzyl)oxazole (6), 2,5-diphenyl-4-tribu-
tylstannanyloxazole (5b) (612 mg, 1.20 mmol) was coupled to
2-iodothiophene (110 µL, 209 mg, 1.0 mmol). Tri-2-furylphos-
phine (46 mg, 200 µmol) was used as the ligand, and a reaction
time of 24 h at 80 °C and purification by flash column chroma-
tography (3% diethyl ether in hexanes) gave 2,5-diphenyl-4-
thiophen-2-yloxazole as a white solid (127 mg, 42%), mp 66-68
°C. IR (KBr) νmax/cm-1 3053, 2923, 2853, and 1560; 1H NMR (300
MHz, CDCl3) δH 7.09 (1H, dd, J ) 5.3, 4.6 Hz), 7.37-7.54 (8H,
m), 7.79-7.82 (2H, m), and 8.15-8.20 (2H, m); 13C NMR (75
MHz, PENDANT, CDCl3) δC 125.8, 126.0, 126.5, 126.8, 127.0,
127.4, 127.7, 128.5, 128.66, 128.8, 130.4, 131.3, 134.6, 145.1, and
160.0; LRMS (APCI) m/z 304 (M + H+).
(2,5-Dip h en yloxa zol-4-yl)-p -t olylm et h a n on e (Ta ble 2,
En tr y 5). Using the same procedure as described for the
preparation of 2,5-diphenyl-4-(4′-vinylbenzyl)oxazole (6), 2,5-
diphenyl-4-tributylstannanyloxazole (5b) (612 mg, 1.20 mmol)
was coupled to p-toluoyl chloride (132 µL, 154 mg, 1.0 mmol).
Triphenylarsine (61 mg, 200 µmol) was used as the ligand, and
a reaction time of 4 h at 65 °C and purification by flash column
chromatography (10% diethyl ether in hexanes) gave (2,5-
diphenyloxazol-4-yl)-p-tolylmethanone as a white solid (234 mg,
69%), mp 110-112 °C. IR (KBr) νmax/cm-1 3058, 2921, and 1652;
1H NMR (300 MHz, CDCl3) δH 2.44 (3H, s), 7.30 (2H, d J 7.9),
7.43-7.51 (6H, m), and 8.07-8.19 (6H, m); 13C NMR (75 MHz,
PENDANT, CDCl3) δC 21.6, 126.6, 127.4, 127.6, 128.4, 128.7,
128.8, 130.0, 130.6, 130.8, 132.1, 134.8, 135.1, 143.8, 154.0, 158.8,
and 188.3; LRMS (APCI) m/z 340 (M + H+).
H+); HRMS (EI) m/z 512.1967 (M + H+) (calcd for C27H38NO120
-
Sn, 512.1975).
2,5-Dip h en yl-4-(4′-vin ylben zyl)oxa zole (6). Tris(dibenzy-
lidineacetone)dipalladium(0) [23 mg, 25 µmol (5 mol % Pd)],
triphenylarsine [61 mg, 200 µmol (20 mol % ligand)], and copper-
(II) oxide [79 mg, 1.00 mmol (1 equiv)] were stirred at room
temperature in 1-methyl-2-pyrrolidinone (10 mL) for 15 min.
4-Vinylbenzyl chloride (157 µL; 170 mg, 1.00 mmol as 90%) was
added, and the resultant mixture stirred for a further 15 min
before a solution of 2,5-diphenyl-4-tributylstannanyloxazole (5b)
(612 mg, 1.20 mmol) in 1-methyl-2-pyrrolidinone (10 mL) was
added. The resultant mixture was heated to 65 °C and stirred
for 4 h, after which time blackening of the mixture had occurred.
The reaction mixture was then stirred with a 10% aqueous
solution of potassium fluoride (75 mL) and diethyl ether (25 mL)
for 1 h before being filtered through a pad of Celite. The pad of
Celite was subsequently rinsed with a further portion of diethyl
ether (25 mL). The aqueous phase was separated and extracted
with a further portion of diethyl ether (25 mL). The combined
(2,5-Dip h en yloxa zol-4-yl)ben za ld eh yd e (Ta ble 2, En tr y
6). Using the same procedure as described for the preparation